Compare · ECL vs WALD
ECL vs WALD
Side-by-side comparison of Ecolab Inc. (ECL) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ECL and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- ECL is the larger of the two at $76.78B, about 345.1x WALD ($222.5M).
- Over the past year, ECL is up 1.8% and WALD is down 24.8% - ECL leads by 26.6 points.
- ECL has been more active in the news (14 items in the past 4 weeks vs 1 for WALD).
- ECL has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Ecolab Inc.
- Waldencast plc
- Price
- $273.00-0.97%
- $1.74+2.65%
- Market cap
- $76.78B
- $222.5M
- 1M return
- -0.32%
- +0.87%
- 1Y return
- +1.79%
- -24.84%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 14
- 1
- Recent ratings
- 25
- 11
Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services worldwide. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, and petrochemical industries. The company's Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest ECL
- Ecolab upgraded by Oppenheimer with a new price target
- SEC Form SCHEDULE 13G filed by Ecolab Inc.
- Director Zillmer John J was granted 130 shares, increasing direct ownership by 0.26% to 49,365 units (SEC Form 4)
- Director Whalen Julie was granted 130 shares, increasing direct ownership by 38% to 472 units (SEC Form 4)
- Director Vautrinot Suzanne M was granted 130 shares, increasing direct ownership by 1% to 11,805 units (SEC Form 4)
- Director Nowell Lionel L Iii was granted 130 shares, increasing direct ownership by 2% to 6,773 units (SEC Form 4)
- Director Mckibben Tracy B was granted 130 shares, increasing direct ownership by 1% to 11,668 units (SEC Form 4)
- Director Maclennan David was granted 176 shares, increasing direct ownership by 0.70% to 25,427 units (SEC Form 4)
- Director Larson Michael was granted 130 shares, increasing direct ownership by 0.68% to 19,166 units (SEC Form 4)
- Director Gross Marion K. was granted 130 shares, increasing direct ownership by 28% to 597 units (SEC Form 4)
Latest WALD
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Sale of Obagi Medical to Bridgepoint
- Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
- Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience
- Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
- Waldencast announces conclusion of SEC investigation
- SEC Form 6-K filed by Waldencast plc